Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthetic Biology02:55

Synthetic Biology

5.6K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.6K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

276
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
276
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

559
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
559
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

249
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
249
Synthetic Disvision of Polynomials01:28

Synthetic Disvision of Polynomials

178
Synthetic division is an efficient algorithmic approach for dividing a polynomial by a linear binomial of the form x - c, where c is a real number. This method is helpful due to its streamlined process, which avoids the more cumbersome steps involved in the traditional long division of polynomials. It simplifies computation and serves as a practical tool for evaluating polynomials and identifying their factors.To perform synthetic division, one begins by listing the coefficients of the...
178
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

539
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
539

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Source apportionment of fine particulate matter (PM<sub>2.5</sub>) personal exposures: findings from the Household Air Pollution Intervention Network (HAPIN) study in rural Guatemala.

Journal of exposure science & environmental epidemiology·2026
Same author

Neighborhood factors and the geography of type 2 diabetes in Malaysia: an ecological based geospatial modelling study.

BMC public health·2026
Same author

Dental caries linked to gestational and early-life secondhand smoke exposure.

Journal of dentistry·2026
Same author

Comparing Performance and Reliability of Collocated Enhanced Children's MicroPEM (ECM) on Gravimetric and Nephelometric PM<sub>2.5</sub> Personal Exposure Samples in Field Measurements in Rural Guatemala.

Indoor air·2026
Same author

Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023.

The American journal of tropical medicine and hygiene·2026
Same author

Personal household air pollution exposure and SARS-CoV-2 antibody responses among women and infants: an analysis within the HAPIN trial.

Environment international·2026

Related Experiment Video

Updated: Feb 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K

Using spatiotemporal models to generate synthetic data for public use.

Harrison Quick1, Lance A Waller2

  • 1Department of Epidemiology and Biostatistics, Drexel University, Philadelphia, PA 19104, United States.

Spatial and Spatio-Temporal Epidemiology
|November 10, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces spatiotemporal Bayesian models to create synthetic heart disease data, protecting privacy while preserving complex data relationships for public health research.

Keywords:
Bayesian data analysisDisclosure riskDisease mappingMultivariate conditional autoregressive modelsSmall area estimation

More Related Videos

Generation of Shear Adhesion Map Using SynVivo Synthetic Microvascular Networks
09:52

Generation of Shear Adhesion Map Using SynVivo Synthetic Microvascular Networks

Published on: May 25, 2014

9.3K
Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

10.8K

Related Experiment Videos

Last Updated: Feb 2, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.6K
Generation of Shear Adhesion Map Using SynVivo Synthetic Microvascular Networks
09:52

Generation of Shear Adhesion Map Using SynVivo Synthetic Microvascular Networks

Published on: May 25, 2014

9.3K
Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

10.8K

Area of Science:

  • Public Health Data Science
  • Biostatistics
  • Geospatial Epidemiology

Background:

  • Public-use data release faces disclosure risks, especially in disease mapping with small counts.
  • Integrating statistical disclosure limitation with small area estimation and disease mapping is underexplored.
  • Small counts in disease mapping present inferential challenges and privacy concerns.

Purpose of the Study:

  • To propose and evaluate spatiotemporal data analysis for generating privacy-preserving synthetic public-use data.
  • To address the intersection of disease mapping, small area estimation, and statistical disclosure limitation.
  • To demonstrate the utility of synthetic data for analyzing health disparities.

Main Methods:

  • Utilized a Bayesian spatiotemporal model to analyze ten years of county-level heart disease death counts across multiple age-groups.
  • The model accounts for spatial, temporal, and inter-age-group dependencies.
  • Generated synthetic data from the posterior predictive distribution of the fitted model.

Main Results:

  • Demonstrated the synthetic data's capacity to preserve key data dependencies (spatial, temporal, age-group).
  • Confirmed the privacy-preserving attributes of the generated synthetic datasets.
  • Showcased comparable estimates of urban/rural disparities between synthetic and suppressed real data.

Conclusions:

  • Spatiotemporal Bayesian modeling offers a robust method for generating synthetic disease mapping data.
  • Synthetic data can effectively balance data utility and privacy protection for public release.
  • This approach facilitates the analysis of health disparities without compromising individual privacy.